Adaptimmune Therapeutics
ADAP
#9234
Rank
โ‚ฌ64.26 M
Marketcap
0,24ย โ‚ฌ
Share price
4.45%
Change (1 day)
-77.43%
Change (1 year)

Annual Reports (10-K)

Latest form 10-K annual reports for Adaptimmune Therapeutics CIK: 0001621227

Thumbnail Adaptimmune Therapeutics 10-K Annual Report 2024

10-K Annual Report 2024

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report 2023

10-K Annual Report 2023

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report 2022

10-K Annual Report 2022

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report 2021

10-K Annual Report 2021

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report 2020

10-K Annual Report 2020

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report 2019

10-K Annual Report 2019

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report 2018

10-K Annual Report 2018

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report 2017

10-K Annual Report 2017

Language: English

View Annual Report (10-K)
Thumbnail Adaptimmune Therapeutics 10-K Annual Report 2016

10-K Annual Report 2016

Language: English

View Annual Report (10-K)